Volume 5 Issue 2 - International Biopharmaceutical Industry

Current Edition

Volume 5 Issue 2

How Scalable Manufacture will Enable Progress for Lentiviral Therapies

In the twenty years since the creation of the first effective CAR-T cells, lentiviral vectors have become valuable tools for the development of ex vivo gene and cell ...

28 June 2022 Volume 5 Issue 2

Continue Reading →

Volume 5 Issue 2

Live Cell Transport – The New Way of Transportation

A new generation of active temperature-controlled and CO2-conditioned transport devices are challenging the existing cell shipment methods. In routine cell culture tr...

28 June 2022 Volume 5 Issue 2

Continue Reading →

Volume 5 Issue 2

Preparing Biopharmaceutical Downstream Processing Supply Chains for Resiliency Post-Pandemic

From monoclonal antibodies (mAbs) that treat ailments such as cancer and arthritis to messenger RNA (mRNA) vaccines to fight a pandemic, biopharma’s place in global h...

28 June 2022 Volume 5 Issue 2

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

How Scalable Manufacture will Enable Progress for Lentiviral Therapies

Live Cell Transport – The New Way of Transportation

Preparing Biopharmaceutical Downstream Processing Supply Chains for Resiliency Post-Pandemic

International Biopharmaceutical Industry